Ngā hua rapu - Roberto Perrone
- E whakaatu ana i te 1 - 6 hua o te 6
-
1
-
2
-
3
Receptor-Drug Interaction: Europium Employment for Studying the Biochemical Pathway of G-Protein-Coupled Receptor Activation mā Antonio, Colabufo Nicola, Grazia, Perrone Maria, Marialessandra, Contino, Francesco, Berardi, Roberto, Perrone
I whakaputaina 2007Text -
4
Cyclohexylpiperazine derivative PB28, a σ2 agonist and σ1 antagonist receptor, inhibits cell growth, modulates P-glycoprotein, and synergizes with anthracyclines in breast cancer mā Amalia Azzariti, Nicola Antonio Colabufo, Francesco Berardi, Letizia Porcelli, Mauro Niso, G. Simone, Roberto Perrone, Angelo Paradiso
I whakaputaina 2006Artigo -
5
-
6
An innovative small molecule for promoting neuroreparative strategies mā Nicola Antonio Colabufo, Marialessandra Contino, Mariangela Cantore, Francesco Berardi, Roberto Perrone, Annamaria Tonazzi, Lara Console, Maria Antonietta Panaro, Heli Savolainen, Gert Luurtsema
I whakaputaina 2018Artigo
Ngā utauta rapu:
Ngā marau whai pānga
Internal medicine
Medicine
Biology
Chemistry
Pharmacology
Receptor
5-HT receptor
Agonist
Biochemistry
Neuroscience
Serotonin
5-HT7 receptor
Antagonist
Anthracycline
Apoptosis
Autism
Autism spectrum disorder
Biotechnology
Breast cancer
Business
Cancer
Cancer cell
Cell culture
Cell growth
Central nervous system
Chemotherapy
Cytotoxic T cell
Disease
Dopamine receptor D1
Doxorubicin